This is a good find Vulcarum. The fact that Teva is launching it's smart inhaler now to the UK general market even without reimbursements like the US is offering is a very positive sign for Adherium's UK operation. Teva would have done it's home work first before making this decision. I don't see any mention of how they plan to integrate their product. Maybe keeping that info close to their chest.
Very interesting article, page-258
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.103M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 435003 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 224800 | 1 |
View Market Depth
| Last trade - 16.12pm 27/09/2024 (20 minute delay) ? |
| ADR (ASX) Chart |
Day chart unavailable